Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 5Recruiting 3Enrolling by invitation 2Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1

Conditions

Breast Neoplasms 6384Neoplasms 5356Prostatic Neoplasms 2964Carcinoma, Non-Small-Cell Lung 2704Colorectal Neoplasms 2674Lung Neoplasms 2262Multiple Myeloma 1656Lymphoma 1598Neoplasm Metastasis 1550Leukemia, Myeloid, Acute 1537Melanoma 1484Pancreatic Neoplasms 1470Ovarian Neoplasms 1420Leukemia 1387Head and Neck Neoplasms 1283Precursor Cell Lymphoblastic Leukemia-Lymphoma 1279Lymphoma, Non-Hodgkin 1226Colonic Neoplasms 1157Carcinoma, Hepatocellular 1141Stomach Neoplasms 1126Leukemia, Lymphocytic, Chronic, B-Cell 1089Brain Neoplasms 1048Rectal Neoplasms 979Lymphoma, Follicular 978Recurrence 971Uterine Cervical Neoplasms 923Glioblastoma 916Carcinoma, Renal Cell 881Lymphoma, Large B-Cell, Diffuse 851Hodgkin Disease 775

Interventions

Selective Serotonin Reuptake Inhibitors 1Dignity Therapy 1Antidepressive Agents, Tricyclic 1Antidepressive Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Depressive Disorder × Clear all
NCT06502483 2026-04-21

PRISM

Dana-Farber Cancer Institute

Phase NA Completed
13 enrolled
Sarcoma

Anxiety Disorders, Depression, Depressive Disorder, Desmoid Tumors

NCT03674138 2026-02-06

Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
99 enrolled

Generalized Anxiety Disorder, Anxiety Disorders, Depression, Depressive Disorder, Major, Depressive Disorder, Neoplasms

NCT05701345 2024-11-04

Study of Virtual Reality-based Medical Device for Patients with Depressive Disorder

Omni C&S

Phase NA Completed
162 enrolled
Lymphoid

Depressive Disorder, Major, Depressive Disorder, Lymphoma, Follicular

NCT03692988 2021-06-15

DTD

University of Zurich

Phase NA Completed
54 enrolled
Lymphoid

Dementia, Depressive Disorder, Lymphoma, Follicular

NCT01077596 2017-05-30

Carcinogenicity Study of Bupropion

GlaxoSmithKline

Completed
50,430 enrolled 23 charts

Depressive Disorder, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡